It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Long Covid results from the damage caused by SARS-CoV-2, involving the release of cytokines and the continuous activation of immune cells. This cross-sectional study investigates leukocyte and cytokine profiles in Long Covid patients in the Amazon, a region where such studies are limited. Blood samples were analysed for differential leukocyte counts and cytokine levels. We suggest elevated lymphocyte counts in hospitalised patients and those with severe COVID-19. Higher eosinophil counts were observed in patients with up to three months of Long Covid, and increased monocyte counts in those with up to six months. IL-2 levels were higher in patients with fewer symptoms and Long Covid duration of more than three months, whereas IL-10 may remain elevated for up to 12 months. We suggest positive correlations between neutrophils, monocytes, eosinophils, and lymphocytes with different cytokines (IFN-γ, IL-6, IL-4, IL-17a, IL-2). Women were associated with lower hospitalisation rates and longer durations of Long Covid; increased lymphocyte counts were linked to hospitalisation due to COVID-19, while higher monocyte counts were associated with Long Covid durations of up to six months. We suggest that Long Covid patients may exhibit alterations in inflammatory markers, indicating a persistently pro-inflammatory microenvironment that tends to diminish after 12 months of Long Covid.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 State University of Pará (UEPA), Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), Marco, Belém, Brazil (GRID:grid.442052.5)
2 Metropolitan University Centre of Amazonia (UNIFAMAZ), Belém, Brazil (GRID:grid.513204.1)
3 State University of Pará (UEPA), Department of Morphology and Physiological Sciences (DMCF), Belém, Brazil (GRID:grid.442052.5)
4 Federal University of Pará (UFPA), Laboratory of Virology (LABVIR), Institute of Biological Sciences (ICB), Belém, Brazil (GRID:grid.271300.7) (ISNI:0000 0001 2171 5249)
5 Brazilian Ministry of Health, Immunology Laboratory, Virology Section, Evandro Chagas Institute (IEC), Health and Environmental Surveillance Secretariat (SVSA), Ananindeua, Brazil (GRID:grid.414596.b) (ISNI:0000 0004 0602 9808)
6 Federal University of Pará (UFPA), Laboratory of Human and Medical Genetics (LGHM), Belém, Brazil (GRID:grid.271300.7) (ISNI:0000 0001 2171 5249)
7 State University of Pará (UEPA), Department of Center for Biological Health Sciences (CCBS), Graduate Program in Parasitic Biology in Amazonia (PPGBPA), Marco, Belém, Brazil (GRID:grid.442052.5); São Paulo University (USP), School of Medicine, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722)